Top Stories
Top Stories
Wires

ASTRAZENECA, MERCK'S LYNPARZA KEEPS PANCREATIC CANCER AT BAY LONGER THAN PLACEBO IN PATIENTS WITH BRCA MUTATIONS - STUDY